News
Partner Organisations
Consensus Statement: NCDs and Immunisation – Advancing Coordinated Advocacy and Action
Provides a shared foundation for advancing adult immunisation as an important component of healthier ageing, NCD prevention, management, and care.
(Recording available) IDC Partner Session at WOHC2026 - Exploring bidirectional links between respiratory viruses & non-communicable diseases
Now available to watch On Demand - IDC session at 9th World One Health Congress in Lisbon, 6 September 2026.
Cost-Effectiveness Analysis of the High-Dose Trivalent Influenza Vaccine in the Elderly Population in Italy
The findings suggest that the high-dose vaccine may improve health outcomes while reducing healthcare costs in people aged 65 and over in Italy.
High-Dose vs Standard-Dose Influenza Vaccines in Older Adults: A Meta-Analysis
Among adults 65 years and older, does high-dose inactivated influenza vaccine (HD-IIV) provide superior protection against hospitalization and mortality compared with the standard dose?
Global influenza epidemiology after 2020: patterns of circulation, epidemic timing and duration, and implications for vaccination strategies
Influenza seasonality is resynchronising after the pandemic shock, but with durable changes in epidemic duration and the types of circulating viruses.
Influenza Vaccine and Associated Infection and Death in California, 2024 to 2025
Among adults aged 65 years and older with laboratory confirmed influenza, vaccination was associated with 29% lower likelihood of death due to influenza-related causes.
Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Updated analysis incorporating new evidence
HD-IIV remains cost-effective in Dutch adults aged ≥60.
Eight vaccines linked to a lower risk of dementia
A growing body of research is beginning to reveal the impact that regular routine vaccines could be having on the likelihood of conditions like dementia.